Alternatively, several studies reported overexpression of Hh ligands, often Shh, and of the Hh transcriptional targets GLI1 and Ptch1 and, thus, the activation of the Hh pathway in breast cancer [11, 16, 17]. This evidence concerns the gene SHH and breast cancer.